Jpmorgan Chase & CO Nevro Corp Call Options Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NVRO
# of Institutions
151Shares Held
39.3MCall Options Held
67.9KPut Options Held
1.59M-
Arrow Mark Colorado Holdings LLC Denver, CO4.39MShares$19 Million0.35% of portfolio
-
Armistice Capital, LLC New York, NY3.73MShares$16.1 Million0.35% of portfolio
-
Black Rock Inc. New York, NY3.6MShares$15.6 Million0.0% of portfolio
-
Glenn Welling Engaged Capital LLC | Newport Beach, Ca2.44MShares$10.6 Million2.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.1MShares$9.05 Million0.0% of portfolio
About NEVRO CORP
- Ticker NVRO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 35,387,800
- Market Cap $153M
- Description
- Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...